Discovering and developing innovative therapeutics for CNS disorders

Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.

Latest Press Releases

Newron: Data on Safinamide to Be Presented at the 14th MDS Meeting

10/06/2010
English ENG  German GER

Newron reports SERENA trial top-line results for ralfinamide

06/05/2010
English ENG  German GER

Investor News

Please click here to view Newron share price information on SIX.